Lumendi is a healthcare company that focuses on developing and applying medical technology to improve patient outcomes, reduce costs, and minimize patient intervention. Founded in 2014, Lumendi holds a worldwide exclusive license to intellectual property developed by Minimally Invasive New Technologies (MINT), a joint program of Weill Cornell Medical College and New York-Presbyterian Hospital. In collaboration with MINT and other partners, Lumendi is developing devices for less invasive endolumenal procedures in the gastrointestinal (GI) tract, primarily in the colon. These devices have the potential to replace invasive laparoscopic and open surgical procedures, making them more efficient and cost-effective. Lumendi also aims to develop additional techniques that improve patient outcomes and enhance the experience for clinicians. By partnering with healthcare leaders, Lumendi strives to understand their needs and develop innovative solutions that will benefit patients and healthcare providers.